J Korean Diabetes > Volume 13(1); 2012 > Article
The Journal of Korean Diabetes 2012;13(1):39-43.
DOI: https://doi.org/10.4093/jkd.2012.13.1.39    Published online March 31, 2012.
식후 고혈당의 약물요법
류혜진
Pharmacotherapy for Postprandial Hyperglycemia in Type 2 Diabetes.
Hye Jin Yoo
Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. deisy21@naver.com
Abstract
A growing body of evidence shows that effective postprandial hyperglycemia management in individuals with type 2 diabetes can reduce the risk of diabetic complications and cardiovascular diseases. Therefore, accurate monitoring and effective intervention for postprandial hyperglycemia is very important in routine clinical practice for type 2 diabetes. Therapeutic modalities for the management of postprandial hyperglycemia include oral antidiabetic drugs (alpha glucosidase inhibitor, meglitinide, dipeptidyl peptidase-IV inhibitor), ultra-short-acting insulin analogues, and incretin mimetics. A detailed understanding of the advantages and disadvantages of various pharmacotherapies and a careful understanding of the underlying physical and social situations of each patient will be of great help to determine the appropriate prescription for postprandial hyperglycemia management.
Key Words: Hyperglycemia, Type 2 diabetes mellitus, Drug therapy


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2021 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer